INS and diabetes mellitus: In multivariable analysis, gain in VO2 peak was significantly negatively associated with final fructosamine (β = −357, p = 0.010) but not with age, gender, baseline fructosamine, diabetes duration, BMI, basal VO2 peak, type of SCA, treatment group (insulin intensive/control) or insulin treatment during CR (Table 4).